Soleno Therapeutics Inc (SLNO)
SG&A Expense Growth
23.22%
Quarterly · Period ending:
SLNO SG&A Expense Growth
Latest reported23.22%period ending
Latest reported23.22%period ending
SLNO Quarterly SG&A Growth (QoQ) (0.00% → 23.22%)
Latest values, visible window
High-resolution chart · PNG
SLNO sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 23.2179% | |
| 21.1092% | |
| 19.5304% | |
| -3.4895% | |
| -21.5639% | |
| -24.1763% | |
| 373.2756% | |
| 22.6983% | |
| 104.6377% | |
| 24.774% | |
| 4.7018% | |
| 11.0371% | |
| 18.8177% | |
| 3.0017% | |
| -5.4722% | |
| -6.6591% | |
| 1.8105% | |
| -6.18% | |
| 12.2971% | |
| -17.2877% | |
| 32.3412% | |
| -0.2216% | |
| 0.3559% | |
| 12.2317% | |
| 24.5647% | |
| -0.4334% | |
| -4.7198% | |
| -15.7555% | |
| 47.3993% | |
| -12.3877% | |
| -11.778% | |
| -5.4097% | |
| 10.8419% | |
| -1.3251% | |
| -22.2323% | |
| 72.5629% | |
| -38.3659% | |
| 18.6089% | |
| -16.5868% | |
| -15.7852% | |
| 12.219% | |
| 1.2055% | |
| 12.5387% | |
| 24.8711% | |
| 25.5142% | |
| 104.045% | |
| -20.0528% | |
| 142.6112% | |
| 56.2553% | |
| -19.3746% | |
| -58.948% | |
| 45.2692% | |
| 0% |